AKT1 and cancer: FTY720 mediates many of its anti-cancer effects through inactivation of the PI3K/Akt pathway 31–34 mediated via a variety of mechanisms which include the inhibition of PI3K 35, increased PTEN expression 36, activation of PP2A 37–39 and SPHK1 inhibition 14,33,34.